Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:1949-1954
Published online before print April 15, 2002, doi: 10.1161/01.CIR.0000015075.89984.46
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
105/16/1949    most recent
01.CIR.0000015075.89984.46v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lila, N.
Right arrow Articles by Carpentier, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lila, N.
Right arrow Articles by Carpentier, A.
Related Collections
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy

(Circulation. 2002;105:1949.)
© 2002 American Heart Association, Inc.


Clinical Investigation and Reports

Human Leukocyte Antigen-G Expression After Heart Transplantation Is Associated With a Reduced Incidence of Rejection

Nermine Lila, DVM; Catherine Amrein, MD; Romain Guillemain, MD; Patrick Chevalier, MD; Christian Latremouille, MD; Jean-Noël Fabiani, MD; Jean Dausset, MD PhD; Edgardo D. Carosella, MD; Alain Carpentier, MD PhD

From the Laboratory for the Study of Cardiac Grafts and Prostheses, University of Pierre et Marie Curie, Broussais Hospital (N.L., A.C.); the Department of Cardiovascular Surgery and Organ Transplantation, Georges Pompidou Hospital (C.A., R.G., P.C., C.L., J.-N.F., A.C.); and Research Institute for Hemato-Immunology, CEA Laboratory, Saint-Louis Hospital (J.D., E.D.C.), Paris, France.

Correspondence to Nermine Lila, DVM, Laboratory for the Study of Cardiac Grafts and Prostheses, University of Pierre et Marie Curie, Broussais Hospital, 96 rue Didot 75014 Paris, France. E-mail nerminelila{at}yahoo.fr

Background Human leukocyte antigen (HLA)-G, a nonclassic major histocompatibility complex class I molecule expressed in the extravillous cytotrophoblast at the feto-maternal interface, is known to protect the fetus from maternal cellular immunity. In a preliminary study, we showed that HLA-G is expressed in the hearts of some patients after heart transplantation.

Methods and Results In the present study, a larger number of patients was investigated to confirm this finding and to look for possible correlations between HLA-G expression and the number and types of rejection. Expression of HLA-G in endomyocardial biopsy specimens was investigated by immunohistochemical analysis, and detection of the soluble HLA-G in the serum was performed by immunoprecipitation followed by Western blot analysis. HLA-G was detected in the biopsy specimens and serum of 9 of 51 patients (18%). The number of episodes of acute rejection was significantly lower in HLA-G-positive patients (1.2±1.1) as compared with HLA-G-negative patients (4.5±2.8) (P<0.001). No chronic rejection was observed in HLA-G-positive patients, whereas 15 HLA-G-negative patients had chronic rejection (P<0.032). A longitudinal study of these patients reveals that the status of HLA-G expression was maintained after 6 months both in serum and in biopsy specimens. During this period, HLA-G-positive patients did not have chronic rejection.

Conclusions There is a significant correlation between rejection and HLA-G expression in the heart after transplantation. HLA-G expression and its effect in reducing the incidence and severity of rejection seem to be stable throughout the evolution.


Key Words: transplantation • genes • rejection • grafting




This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Bahri, A. Naji, C. Menier, B. Charpentier, E. D. Carosella, N. Rouas-Freiss, and A. Durrbach
Dendritic Cells Secrete the Immunosuppressive HLA-G Molecule upon CTLA4-Ig Treatment: Implication in Human Renal Transplant Acceptance
J. Immunol., December 1, 2009; 183(11): 7054 - 7062.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Sheshgiri, V. Rao, L. C. Tumiati, R. Xiao, J. L. Prodger, M. Badiwala, C. Librach, and D. H. Delgado
Progesterone Induces Human Leukocyte Antigen-G Expression in Vascular Endothelial and Smooth Muscle Cells
Circulation, September 30, 2008; 118(14_suppl_1): S58 - S64.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. D. Carosella, B. Favier, N. Rouas-Freiss, P. Moreau, and J. LeMaoult
Beyond the increasing complexity of the immunomodulatory HLA-G molecule
Blood, May 15, 2008; 111(10): 4862 - 4870.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Naji, S. Le Rond, A. Durrbach, I. Krawice-Radanne, C. Creput, M. Daouya, J. Caumartin, J. LeMaoult, E. D. Carosella, and N. Rouas-Freiss
CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance
Blood, December 1, 2007; 110(12): 3936 - 3948.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. Feger, E. Tolosa, Y.-H. Huang, A. Waschbisch, T. Biedermann, A. Melms, and H. Wiendl
HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation
Blood, July 15, 2007; 110(2): 568 - 577.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
T. V. F. Hviid
HLA-G in human reproduction: aspects of genetics, function and pregnancy complications
Hum. Reprod. Update, May 1, 2006; 12(3): 209 - 232.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Le Rond, C. Azema, I. Krawice-Radanne, A. Durrbach, C. Guettier, E. D. Carosella, and N. Rouas-Freiss
Evidence to Support the Role of HLA-G5 in Allograft Acceptance through Induction of Immunosuppressive/ Regulatory T Cells.
J. Immunol., March 1, 2006; 176(5): 3266 - 3276.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Bahri, F. Hirsch, A. Josse, N. Rouas-Freiss, N. Bidere, A. Vasquez, E. D. Carosella, B. Charpentier, and A. Durrbach
Soluble HLA-G Inhibits Cell Cycle Progression in Human Alloreactive T Lymphocytes
J. Immunol., February 1, 2006; 176(3): 1331 - 1339.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Rouas-Freiss, P. Moreau, S. Ferrone, and E. D. Carosella
HLA-G Proteins in Cancer: Do They Provide Tumor Cells with an Escape Mechanism?
Cancer Res., November 15, 2005; 65(22): 10139 - 10144.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
H. Wiendl, U. Feger, M. Mittelbronn, C. Jack, B. Schreiner, C. Stadelmann, J. Antel, W. Brueck, R. Meyermann, A. Bar-Or, et al.
Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity
Brain, November 1, 2005; 128(11): 2689 - 2704.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. Blaschitz, H. Juch, A. Volz, H. Hutter, C. Daxboeck, G. Desoye, and G. Dohr
The soluble pool of HLA-G produced by human trophoblasts does not include detectable levels of the intron 4-containing HLA-G5 and HLA-G6 isoforms
Mol. Hum. Reprod., October 1, 2005; 11(10): 699 - 710.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
J. LeMaoult, N. Rouas-Freiss, and E. D. Carosella
HLA-G5 expression by trophoblast cells: the facts
Mol. Hum. Reprod., October 1, 2005; 11(10): 719 - 722.
[Full Text] [PDF]


Home page
FASEB J.Home page
J. S. Hunt, M. G. Petroff, R. H. McIntire, and C. Ober
HLA-G and immune tolerance in pregnancy
FASEB J, May 1, 2005; 19(7): 681 - 693.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
I. Noci, B. Fuzzi, R. Rizzo, L. Melchiorri, L. Criscuoli, S. Dabizzi, R. Biagiotti, S. Pellegrini, A. Menicucci, and O.R. Baricordi
Embryonic soluble HLA-G as a marker of developmental potential in embryos
Hum. Reprod., January 1, 2005; 20(1): 138 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. Le Friec, F. Gros, Y. Sebti, V. Guilloux, C. Pangault, R. Fauchet, and L. Amiot
Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules
J. Leukoc. Biol., December 1, 2004; 76(6): 1125 - 1133.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. M. Hodgson, A. Behfar, L. V. Zingman, G. C. Kane, C. Perez-Terzic, A. E. Alekseev, M. Puceat, and A. Terzic
Stable benefit of embryonic stem cell therapy in myocardial infarction
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H471 - H479.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. LeMaoult, I. Krawice-Radanne, J. Dausset, and E. D. Carosella
HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells
PNAS, May 4, 2004; 101(18): 7064 - 7069.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. J. Morales, J. L. Pace, J. S. Platt, T. A. Phillips, K. Morgan, A. T. Fazleabas, and J. S. Hunt
Placental Cell Expression of HLA-G2 Isoforms Is Limited to the Invasive Trophoblast Phenotype
J. Immunol., December 1, 2003; 171(11): 6215 - 6224.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
E H Kemp, R A Metcalfe, P F Watson, and A P Weetman
HLA-G does not have a pathophysiological role in Graves' disease
J. Clin. Pathol., June 1, 2003; 56(6): 475 - 477.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Moreau, G. Mouillot, P. Rousseau, C. Marcou, J. Dausset, and E. D. Carosella
HLA-G gene repression is reversed by demethylation
PNAS, February 4, 2003; 100(3): 1191 - 1196.
[Abstract] [Full Text] [PDF]